Treatment a ‘gray area’ for FDA (Boston Herald)

The breast augmentation of the future may rely on stem cells and not silicone, but for now an emerging science presents a “gray area” for the Food and Drug Administration,…

More: continued here

You can respond, or trackback from your own site.